Checked Jul 27, 2026
What GLP-1 programs actually charge. The 2026 telehealth price report.
We checked every published price across US cash-pay GLP-1 telehealth programs. The gap from cheapest flat-fee program to most expensive is $299 a month for the same drug class. Here is what the data shows.
The cheapest published all-in cash price across the GLP-1 programs we track is $149 a month (compounded semaglutide). The most expensive cash-pay path with a published all-in is $448 a month (9amHealth, branded medication). That is a $299 a month gap for the same drug class, a 3.0x range, before insurance enters the picture.
- The cash spread is $149 to $448 a month across the programs we track, a 3.0x range for the same drug class.
- 8 of the programs we track advertise a teaser price below the real ongoing cost. The biggest verified gap right now is Hims & Hers: $188 first month, then $448/mo ongoing.
- Compounded semaglutide (from $149 at entry tiers, $178 flat ongoing) undercuts branded Wegovy (from $299 all-in through the programs we track, $1,349 retail) for the same active molecule.
- Prices move both ways, and the ongoing rate is where the increases land. Noom swung between $249 and $279 across June (now $249), Found removed its cheapest 12-month tier, Ivim raised its floor by $25/mo.
- Insurance cuts the effective cost by up to about 90%, from branded cash prices of $299 and up down to a $25 to $50 copay when prior authorization is approved.
- Compounded tirzepatide ($199 to $299) runs at or below the branded Zepbound vial price ($299 to $449 by dose) for the same active molecule.
- 4 of the programs we track do not publish a complete all-in maintenance price (Henry Meds, 9amHealth, Lifeforce, Push Health). Strut Health publishes an entry price only; its row below is annotated.
The cash-pay spread, lowest to highest
These are the verified all-in monthly figures (membership, medication and fees together) each program publishes, the same headline number our chart and price index rank by. Programs marked “insured” quote an insurance-dependent floor, with cash prices substantially higher. A “steps up by dose” note means the published cost rises above the figure shown at higher doses. 4 programs with no published all-in figure are named under the table.
| Program | All-in monthly | Medication | Lock-in |
|---|---|---|---|
| Strut Health | $149 (steps up by dose) | Compounded semaglutide | Month-to-month |
| Found | $169 (steps up by dose) | Compounded semaglutide | 12-mo lock-in |
| Mochi Health | $178 | Compounded semaglutide | Month-to-month |
| Eden | $198 | Compounded semaglutide | 3-mo minimum |
| Shed | $199 (steps up by dose) | Compounded semaglutide | Prepaid plan |
| Ivim Health | $200 (steps up by dose) | Compounded semaglutide | 4-mo minimum |
| Calibrate | $224 (insured) | Branded | 3-mo minimum |
| Noom Med | $249 (steps up by dose) | Compounded semaglutide | Month-to-month |
| Lemonaid Health | $298 (steps up by dose) | Compounded semaglutide | Month-to-month |
| Medvi | $299 | Compounded semaglutide | Month-to-month |
| Knownwell | $299 (steps up by dose) | Wegovy pill | Month-to-month |
| Amazon Pharmacy | $299 (estimated) | Wegovy pill | No lock-in |
| Sam's Club Member Health | $299 | Wegovy pill | No lock-in |
| Hone Health | $315 (steps up by dose) | Liraglutide | Month-to-month |
| Walgreens Weight Management | $348 (estimated; steps up by dose) | Wegovy | No lock-in |
| Ro Body | $373 (steps up by dose) | Wegovy pill | Month-to-month |
| WeightWatchers Clinic | $373 (steps up by dose) | Wegovy pill | 12-mo lock-in |
| GoodRx for Weight Loss | $388 | Wegovy injection | Month-to-month |
| Sesame Care | $398 (estimated; steps up by dose) | Wegovy pill | Month-to-month |
| Costco / Success by Sesame | $408 | Wegovy injection | Month-to-month |
| Hims & Hers | $448 (estimated; steps up by dose) | Wegovy pill | Month-to-month |
| LifeMD | $448 (steps up by dose) | Wegovy pill | Month-to-month |
Source: our price index, field for the all-in monthly cost, checked every Monday against each program's published pricing. No published all-in figure: Henry Meds, 9amHealth, Lifeforce, Push Health. Henry Meds moved pricing behind signup in June 2026; Embla is employer-only; Push Health rates are provider-set.
Teaser price vs real maintenance price
The most common pricing trap is the headline number that applies only to month one or the starter dose. The verified gaps, largest first:
| Program | Advertised teaser | Real maintenance | Gap |
|---|---|---|---|
| Hims & Hers | $188 first month | $448/mo ongoing | +$260/mo |
| Ro Body | $188 first month | $373/mo ongoing | +$185/mo |
| Eden | $138 first month | $198/mo ongoing | +$60/mo |
| Mochi Health | $138 first month | $178/mo ongoing | +$40/mo |
| Noom Med | $129 to start (first 4-week supply) | $249/mo ongoing | +$120/mo |
| WeightWatchers Clinic | $25/mo membership for 3 months | $74/mo membership, med separate | +$49/mo membership |
We list both the entry price and the maintenance price on every program row, and the mechanics are in how GLP-1 telehealth pricing works.
Compounded vs branded, same molecule
The single largest driver of the price spread is compounded versus branded. The active ingredient is the same; the regulatory pathway and the price are not.
| Molecule | Compounded (telehealth) | Branded direct (cash) | Branded retail (cash) | Insured copay |
|---|---|---|---|---|
| Semaglutide | $178 to $299/mo | $299/mo Wegovy pill, $349/mo injection | $1,349/mo (Wegovy) | $25 to $50/mo |
| Tirzepatide | $199 to $349/mo | $299 to $449/mo (Zepbound vials) | $1,086/mo (Zepbound) | $25 to $50/mo |
| Orforglipron (Foundayo) | Not compoundable | $149/mo (lowest dose) | No generic | $25/mo with card |
Retail and direct prices from the Wegovy and Zepbound drug pages. Full path-by-path breakdown in the GLP-1 cost guide.
Price moves so far in 2026
Every confirmed market move in the tracked window (May 25 to June 10, 2026) was upward, except a small cut to one program's first-month intro. No program reduced its ongoing maintenance price.
| Date | Program | Old | New | Direction |
|---|---|---|---|---|
| Jun 23, 2026 | Noom Med | $249/mo ongoing | $279/mo ongoing | Higher |
| Jun 10, 2026 | Found | $179/mo (12-month) | $199/mo (old tier removed) | Higher |
| Jun 10, 2026 | Ivim Health | ~$150/mo (12-mo prepay) | ~$175/mo (tier eliminated) | Higher |
| May 25, 2026 | Hims & Hers | $49 first-month | $39 first-month | Lower (entry only) |
Every price change is logged with a date on the price-change record.
Methodology
We track the all-in monthly cost for each GLP-1 telehealth program operating in the United States. All-in means the membership fee plus medication where the program bundles both; where medication bills separately, we report the program fee plus the published cash medication price or, for insurance-first programs, the program fee plus the typical copay. We track the maintenance-dose price, not the starter or intro tier.
Prices are checked every Monday against each program's published pricing page, help center, or official pricing communications. Where a program's live site blocks automated access, we confirm through a web search of the program's own published materials. We do not sign up, pay, or purchase to verify a price; we read the figure the program publishes. Where a program does not publish its maintenance price, we flag the row rather than estimate. All prices are in US dollars, cash-pay, United States only. The tracking window for this report is May 25 to June 10, 2026.
GLP Chart. “GLP-1 Telehealth Price Report 2026.” June 2026. glpchart.com/glp1-price-report-2026. Journalists and researchers are welcome to cite these figures with a link. For the live numbers behind this report, updated every Monday, see the price index.
Frequently asked questions
Why does the same drug cost $178 a month at one program and $1,349 at the pharmacy?
The $178 a month (Mochi Health) is compounded semaglutide, prepared by a 503A pharmacy under prescription. The $1,349 a month is the retail cash price for branded Wegovy from Novo Nordisk. Same active molecule, different regulatory pathway, different manufacturing oversight, very different price. Insurance can cut the branded price to $25 to $50 a month for patients who qualify and get prior authorization approved.
Are the teaser prices legal?
Nothing in the data suggests any program advertises its intro price unlawfully. What is documented is that 8 of the programs we track advertise a first-month or entry-dose price below the ongoing maintenance cost, sometimes by more than $200 a month. The practice is widespread. A shopper who compares on the advertised entry price and does not read the fine print will be surprised when month two bills.
Which programs have lock-in contracts?
Four require a multi-month commitment for their lowest price: Found (12-month plan for $169 a month cash), WeightWatchers Clinic (12-month commitment), Calibrate (3-month minimum, paid upfront), and Embla (12-month curriculum). Ivim Health requires a 4-month medication prepay to reach its cheapest per-month rate.
How often do GLP-1 prices change?
Confirmed moves land most months, in both directions. Noom Med's Full-Dose GLP-1Rx moved between $249 and $279 a month across June 2026 (the verified rate now: $249), Found removed its cheapest 12-month tier, and Ivim eliminated its cheapest prepay tier, raising its floor by at least $25 a month. A first-month intro cut is the most common reduction, and it does not change the ongoing price. Live changes are logged with dates on the price-change record.
Does insurance actually work for these drugs?
For some patients, yes. Calibrate, WeightWatchers Clinic and 9amHealth are built around insurance-first models for branded Wegovy or Zepbound. When approved, the copay typically runs $25 to $50 a month versus branded cash prices from $299 a month. The catch: prior authorization is not guaranteed, approval can take two or more weeks, and some employers exclude weight-loss GLP-1s entirely. Compounded programs do not accept insurance.
What is the cheapest way to access tirzepatide?
The cheapest published compounded tirzepatide all-in is about $199 to $299 a month. Mochi's tirzepatide tier is $278 a month flat, Noom's GLP-1Rx Plus is $299, and Found starts at $199 on the 12-month plan (its compounded semaglutide is cheaper at $169). The branded alternative, Zepbound vials through LillyDirect, runs $299 to $449 a month cash. Compounded tirzepatide carries the highest active regulatory exposure of any GLP-1 here, with Eli Lilly pursuing litigation against compounders through 2025 and 2026.
See the live chart of every program →
